APA (7th ed.) Citation

CK, L., S, L., YY, S., K, R., A, N., A, S., . . . C, H. (2026). Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 21(5), 103549. https://doi.org/10.1016/j.jtho.2026.01.001

Chicago Style (17th ed.) Citation

CK, Lee, et al. "Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 21, no. 5 (2026): 103549. https://doi.org/10.1016/j.jtho.2026.01.001.

MLA (9th ed.) Citation

CK, Lee, et al. "Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 21, no. 5, 2026, p. 103549, https://doi.org/10.1016/j.jtho.2026.01.001.